Actively Recruiting
Hospital at Home for Elderly Acute Ill Patients
Led by Defactum, Central Denmark Region · Updated on 2024-08-09
849
Participants Needed
3
Research Sites
269 weeks
Total Duration
On this page
Sponsors
D
Defactum, Central Denmark Region
Lead Sponsor
I
Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark
Collaborating Sponsor
AI-Summary
What this Trial Is About
Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.
CONDITIONS
Official Title
Hospital at Home for Elderly Acute Ill Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 65 years and older
- Diagnosed with stable acute medical conditions such as cystitis, erysipelas, or pneumonia
- Living in their own home or a nursing home before entering the study
- Residing in one of the three municipalities: Viborg, Skive, or Silkeborg
- Have been seen by their general practitioner or pre-hospital service for the current illness
- Speak and understand Danish
- Able to give informed consent to participate in the study
You will not qualify if you...
- Unable to give written consent
- Municipal acute team care capacity is fully utilized
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Silkeborg municipality
Silkeborg, Denmark, 8600
Actively Recruiting
2
Skive municipality
Skive, Denmark
Actively Recruiting
3
Viborg municipality
Viborg, Denmark
Actively Recruiting
Research Team
C
Camilla Palmhøj Nielsen, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here